Taken together, the bioactivities of FGF15 on hepatocytes, instead of alleviating lipid accumulation, was shown to up-regulate FGFR4, while compromised FGF21 worsened steatosis in hepatocytes. The gene discussed is FGFR4; the disease is steatosis.